Re: Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs

被引:3
|
作者
Farrell, Mike [1 ]
Adams, Rob [2 ]
von Pfeil, Dirsko J. F. [3 ]
机构
[1] Vetlessons, 25 James Carter Rd, Bury St Edmunds IP28 7DE, England
[2] Paragon Vet Referrals, Red Hall Crescent, Wakefield WF1 2DF, England
[3] PLLC, Small Anim Surg Locum, Dallas, TX USA
来源
VETERINARY JOURNAL | 2024年 / 305卷
关键词
Bedinvetmab; Librela; Rapidly progressive osteoarthritis; RPOA;
D O I
10.1016/j.tvjl.2024.106104
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
We are writing to express our interest in the article entitled "Laboratory safety evaluation of bedinvetmab, a canine anti -nerve growth factor monoclonal antibody, in dogs", published in the October, 2021 issue of The Veterinary Journal , Volume 276, 105733, by Krautmann and others.
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Anti-nerve growth factor antibody improves airway hyperresponsiveness by down-regulating RhoA
    Chen, Jingying
    Kou, Lijie
    Kong, Lingfei
    JOURNAL OF ASTHMA, 2018, 55 (10) : 1079 - 1085
  • [22] Single Cycle Structure-Based Humanization of an Anti-Nerve Growth Factor Therapeutic Antibody
    Covaceuszach, Sonia
    Marinelli, Sara
    Krastanova, Ivet
    Ugolini, Gabriele
    Pavone, Flaminia
    Lamba, Doriano
    Cattaneo, Antonino
    PLOS ONE, 2012, 7 (03):
  • [23] Anti-nerve growth factor in pain management: current evidence
    Chang, David S.
    Hsu, Eugene
    Hottinger, Daniel G.
    Cohen, Steven P.
    JOURNAL OF PAIN RESEARCH, 2016, 9 : 373 - 383
  • [24] FLUORESCENCE STUDIES USING ANTI-NERVE GROWTH-FACTOR
    KUMAR, S
    TAYLOR, G
    WAGHE, MA
    STEWARD, JK
    EXPERIMENTAL CELL RESEARCH, 1972, 74 (01) : 170 - &
  • [25] Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice
    Capsoni, S
    Giannotta, S
    Cattaneo, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12432 - 12437
  • [26] Anti-nerve growth factor antibody attenuates chronic morphine treatment-induced tolerance in the rat
    Bopaiah P. Cheppudira
    Alex V. Trevino
    Lawrence N. Petz
    Robert J. Christy
    John L. Clifford
    BMC Anesthesiology, 16
  • [27] The effects of anti-nerve growth factor monoclonal antibodies on developing basal forebrain neurons are transient and reversible
    Molnar, M
    Tongiorgi, E
    Avignone, E
    Gonfloni, S
    Ruberti, F
    Domenici, L
    Cattaneo, A
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (10) : 3127 - 3140
  • [28] Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects
    Jason M. Gow
    Wayne H. Tsuji
    Gary J. Williams
    Daniel Mytych
    David Sciberras
    Shawn L. Searle
    Tim Mant
    John P. Gibbs
    Arthritis Research & Therapy, 17
  • [29] EVALUATION OF EFFECTS OF NERVE GROWTH-FACTOR AND ANTI-NERVE GROWTH-FACTOR ON DEVELOPMENT OF CENTRAL CATECHOLAMINE-CONTAINING NEURONS
    KONKOL, RJ
    MAILMAN, RB
    BENDEICH, EG
    GARRISON, AM
    MUELLER, RA
    BREESE, GR
    BRAIN RESEARCH, 1978, 144 (02) : 277 - 285
  • [30] Anti-nerve growth factor antibody attenuates chronic morphine treatment-induced tolerance in the rat
    Cheppudira, Bopaiah P.
    Trevino, Alex V.
    Petz, Lawrence N.
    Christy, Robert J.
    Clifford, John L.
    BMC ANESTHESIOLOGY, 2016, 16